Skip to main content
PGNY
NASDAQ Industrial Applications And Services

Progyny Reports Strong 2025 Financial Results and Active Share Repurchase Program in Annual 10-K

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$21.06
Mkt Cap
$1.918B
52W Low
$17.977
52W High
$28.75
Market data snapshot near publication time

summarizeSummary

Progyny filed its annual 10-K, confirming strong 2025 financial results with increased revenue and profitability, an expanded gross margin, and significant share repurchases under a new $200 million program.


check_boxKey Events

  • Strong 2025 Financial Performance Confirmed

    Progyny reported a 10% increase in revenue to $1.29 billion, a 7.7% rise in net income to $58.5 million, and an 11.7% growth in Adjusted EBITDA to $222.1 million for the fiscal year ended December 31, 2025. Gross margin also expanded by 190 basis points to 23.6%.

  • Active Share Repurchase Program

    The company authorized a new $200 million share repurchase program in November 2025. As of the filing date (February 27, 2026), Progyny has already repurchased $159.4 million worth of common stock under this program, with $116.4 million remaining available.

  • Enhanced Financial Flexibility with New Credit Facility

    Progyny entered into a $200 million revolving credit facility on July 1, 2025, which remained undrawn as of the filing date, providing additional liquidity and financial flexibility.

  • COO Adopts 10b5-1 Trading Plan

    Chief Operating Officer Melissa Cummings adopted a Rule 10b5-1 trading plan on December 19, 2025, to sell up to 24,062 shares of common stock by March 31, 2027. This is a routine, pre-planned sale.


auto_awesomeAnalysis

This 10-K filing confirms Progyny's robust financial performance for fiscal year 2025, building on the preliminary results announced in yesterday's 8-K. The report details significant growth in revenue, net income, and Adjusted EBITDA, alongside an impressive expansion in gross margin. The company's active share repurchase program, with $159.4 million already executed under a new $200 million authorization, signals strong capital return to shareholders and management's confidence in the company's valuation. The establishment of a new $200 million revolving credit facility further enhances financial flexibility. While the core earnings figures were previously disclosed, this comprehensive annual report provides crucial audited details, risk factors, and a deeper understanding of the company's strategic direction and financial health, making it highly important for investors.

At the time of this filing, PGNY was trading at $21.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $17.98 to $28.75. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed PGNY - Latest Insights

PGNY
Apr 16, 2026, 9:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
PGNY
Apr 10, 2026, 8:34 AM EDT
Filing Type: DEFA14A
Importance Score:
8
PGNY
Apr 10, 2026, 8:33 AM EDT
Filing Type: DEF 14A
Importance Score:
8
PGNY
Mar 31, 2026, 4:33 PM EDT
Filing Type: PRE 14A
Importance Score:
8
PGNY
Mar 13, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
PGNY
Feb 27, 2026, 9:18 AM EST
Filing Type: 10-K
Importance Score:
8
PGNY
Feb 26, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
PGNY
Jan 12, 2026, 8:12 AM EST
Filing Type: 8-K
Importance Score:
7